Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xiaflex
Pharma
Trial results set up Keenova to gain 3rd indication for Xiaflex
A positive phase 3 trial of patients with plantar fibromatosis could set Keenova Therapeutics’ Xiaflex up for approval in a third indication.
Kevin Dunleavy
Jul 8, 2026 11:27am
Keenova launches ‘Don't Be a Viking’ Dupuytren's campaign
May 5, 2026 2:11am
Mallinckrodt, Endo become Keenova following generics spinoff
Nov 11, 2025 9:54am
Endo hands Reddit AMA starring role in Xiaflex awareness push
Sep 9, 2025 9:30am
Endo builds on ‘Bent Carrot’ campaign for fresh Xiaflex push
Aug 12, 2025 12:59pm
Endo debuts first branded Xiaflex ad for Dupuytren's contracture
Feb 26, 2025 1:25pm
